Back to Search Start Over

Occurrence of pulmonary embolism related to COVID-19

Authors :
Marie Hauguel-Moreau
Céline Bégué
Quentin De Baynast
Nicolas Mansencal
Hazrije Mustafic
Guillaume Geri
Robert Carlier
Mostafa El Hajjam
Anne-Sophie Lot
Olivier Dubourg
Antoine Vieillard-Baron
Sébastien Beaune
Thierry Chinet
Service de cardiologie et maladies vasculaires [CHU Ambroise Paré]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Ambroise Paré [AP-HP]
Centre de recherche en épidémiologie et santé des populations (CESP)
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay
Handicap neuromusculaire : Physiopathologie, Biothérapie et Pharmacologies appliquées (END-ICAP)
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Hôpital Ambroise Paré [AP-HP]
Université de Versailles Saint-Quentin-en-Yvelines - UFR Sciences de la santé Simone Veil (UVSQ Santé)
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)
Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie (BECCOH)
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Saclay
Optimisation thérapeutique en Neuropsychopharmacologie (OPTeN (UMR_S_1144 / U1144))
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
HAL UVSQ, Équipe
Source :
Journal of Thrombosis and Thrombolysis, Journal of Thrombosis and Thrombolysis, Springer Verlag (Germany), 2021, 52 (1), pp.69-75. ⟨10.1007/s11239-020-02292-4⟩
Publication Year :
2020
Publisher :
Springer Science and Business Media LLC, 2020.

Abstract

Recent reports have suggested an increased risk of pulmonary embolism (PE) related to COVID-19. The aim of this cohort study is to compare the incidence of PE during a 3-year period and to assess the characteristics of PE in COVID-19. We studied consecutive patients presenting with PE (January 2017–April 2020). Clinical presentation, computed tomography (CT) and biological markers were systematically assessed. We recorded the global number of hospitalizations during the COVID-19 pandemic and during the same period in 2018-2019. We included 347 patients: 326 without COVID-19 and 21 with COVID-19. Patients with COVID-19 experienced more likely dyspnea (p=0.04), had lower arterial oxygen saturation (p

Details

ISSN :
1573742X and 09295305
Volume :
52
Database :
OpenAIRE
Journal :
Journal of Thrombosis and Thrombolysis
Accession number :
edsair.doi.dedup.....d50b9a8ce56c31a9a0fcf42296ab9c15
Full Text :
https://doi.org/10.1007/s11239-020-02292-4